Search research articles
Contact Us
Filters
Showing results (781-790 of 802) with videos related to
Page
of 81
Sort By:
Advanced Materials (Deerfield Beach, Fla.)
|
March 1, 2021
Whole-Voltage-Range Oxygen Redox in P2-Layered Cathode Materials for Sodium-Ion Batteries
Xun-Lu Li, Tian Wang, Yifei Yuan, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
January 29, 2019
Interleukin 22 Expands Transit-Amplifying Cells While Depleting Lgr5<sup>+</sup> Stem Cells via Inhibition of Wnt and Notch Signaling
Juan-Min Zha, Hua-Shan Li, Qian Lin, et al.
Journal of Medicinal Chemistry
|
September 2, 2009
Synthesis, potency, and in vivo evaluation of 2-piperazin-1-ylquinoline analogues as dual serotonin reuptake inhibitors and serotonin 5-HT1A receptor antagonists
Dahui Zhou, Gary P Stack, Jennifer Lo, et al.
BMC Cardiovascular Disorders
|
November 26, 2020
Poor cardiovascular health status among Chinese women
Tian-Wen Han, Yu-Qi Liu, Wei Dong, et al.
Science Advances
|
October 22, 2025
Leptin as a key driver for organ fibrogenesis
Xue-Nan Sun, Shiuhwei Chen, Shangang Zhao, et al.
Journal of Medicinal Chemistry
|
June 27, 2003
Design and synthesis of poly ADP-ribose polymerase-1 inhibitors. 2. Biological evaluation of aza-5[H]-phenanthridin-6-ones as potent, aqueous-soluble compounds for the treatment of ischemic injuries
Dana Ferraris, Yao-Sen Ko, Thomas Pahutski, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
July 3, 2023
Male-Biased Gut Microbiome and Metabolites Aggravate Colorectal Cancer Development
Ling Wang, Yi-Xuan Tu, Lu Chen, et al.
Microbiome
|
November 29, 2018
The chicken gut metagenome and the modulatory effects of plant-derived benzylisoquinoline alkaloids
Peng Huang, Yan Zhang, Kangpeng Xiao, et al.
Science Translational Medicine
|
November 22, 2023
Hyperleptinemia contributes to antipsychotic drug-associated obesity and metabolic disorders
Shangang Zhao, Qian Lin, Wei Xiong, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 16, 2009
WS-50030 [7-{4-[3-(1H-inden-3-yl)propyl]piperazin-1-yl}-1,3-benzoxazol-2(3H)-one]: a novel dopamine D2 receptor partial agonist/serotonin reuptake inhibitor with preclinical antipsychotic-like and antidepressant-like activity
Julie A Brennan, Radka Graf, Steven M Grauer, et al.
Page
of 81
Search research articles
Search
Showing results (781-790 of 802) with videos related to
Sort By:
Page
of 81
Advanced Materials (Deerfield Beach, Fla.)
|
March 1, 2021
Whole-Voltage-Range Oxygen Redox in P2-Layered Cathode Materials for Sodium-Ion Batteries
Xun-Lu Li, Tian Wang, Yifei Yuan, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
January 29, 2019
Interleukin 22 Expands Transit-Amplifying Cells While Depleting Lgr5<sup>+</sup> Stem Cells via Inhibition of Wnt and Notch Signaling
Juan-Min Zha, Hua-Shan Li, Qian Lin, et al.
Journal of Medicinal Chemistry
|
September 2, 2009
Synthesis, potency, and in vivo evaluation of 2-piperazin-1-ylquinoline analogues as dual serotonin reuptake inhibitors and serotonin 5-HT1A receptor antagonists
Dahui Zhou, Gary P Stack, Jennifer Lo, et al.
BMC Cardiovascular Disorders
|
November 26, 2020
Poor cardiovascular health status among Chinese women
Tian-Wen Han, Yu-Qi Liu, Wei Dong, et al.
Science Advances
|
October 22, 2025
Leptin as a key driver for organ fibrogenesis
Xue-Nan Sun, Shiuhwei Chen, Shangang Zhao, et al.
Journal of Medicinal Chemistry
|
June 27, 2003
Design and synthesis of poly ADP-ribose polymerase-1 inhibitors. 2. Biological evaluation of aza-5[H]-phenanthridin-6-ones as potent, aqueous-soluble compounds for the treatment of ischemic injuries
Dana Ferraris, Yao-Sen Ko, Thomas Pahutski, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
July 3, 2023
Male-Biased Gut Microbiome and Metabolites Aggravate Colorectal Cancer Development
Ling Wang, Yi-Xuan Tu, Lu Chen, et al.
Microbiome
|
November 29, 2018
The chicken gut metagenome and the modulatory effects of plant-derived benzylisoquinoline alkaloids
Peng Huang, Yan Zhang, Kangpeng Xiao, et al.
Science Translational Medicine
|
November 22, 2023
Hyperleptinemia contributes to antipsychotic drug-associated obesity and metabolic disorders
Shangang Zhao, Qian Lin, Wei Xiong, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 16, 2009
WS-50030 [7-{4-[3-(1H-inden-3-yl)propyl]piperazin-1-yl}-1,3-benzoxazol-2(3H)-one]: a novel dopamine D2 receptor partial agonist/serotonin reuptake inhibitor with preclinical antipsychotic-like and antidepressant-like activity
Julie A Brennan, Radka Graf, Steven M Grauer, et al.
Page
of 81